Common questions about Онбрез Бризхалер (FAQ)
Q: How quickly will I feel the effect after using Onbrez Breezhaler?
Studies and official information indicate that the airway-widening effect, known as bronchodilation, occurs rapidly. Clinical studies indicate that this effect is experienced rapidly, typically within a few minutes after the first dose is inhaled. The medication is designed to sustain this benefit continuously over 24 hours.
Q: Does Onbrez Breezhaler combine with common over-the-counter cold medicines?
Official regulatory documents do not specifically list every over-the-counter cold medicine interaction. However, caution is advised when using this drug with any medicine that may increase heart rate or blood pressure, as Onbrez Breezhaler itself can cause these effects. Information regarding combination use with specific cold medicines is best reviewed with a healthcare professional.
Q: Is there a risk of interaction with herbal supplements or teas?
According to the official product information, there are no specific warnings or mandatory time separations documented regarding interactions with general herbal products or teas. This means regulatory labeling does not identify a specific risk with general use, but it does not cover all possible supplements.
Q: What should I do if I accidentally inhale the powder?
The capsule contains a powder that is specifically designed to be inhaled using the Breezhaler device. Inhaling the powder from the capsule is the intended method of administration. If there is uncertainty about the inhalation procedure, patients should follow the specific guidance provided in the official Instructions for Use to ensure the full dosage is received. The capsule is not intended to be swallowed.
Q: Why is the drug in the form of capsules for inhalation and not a spray?
The medication is supplied as an inhalation powder contained within hard capsules, which must be administered via the dedicated Breezhaler inhaler. This formulation uses a Dry Powder Inhaler (DPI) system. This method of delivery is the selected design choice for the active substance, Indacaterol, to ensure targeted and effective delivery directly into the airways.
Q: Can Onbrez Breezhaler be used if I don't have COPD?
According to official regulatory documents, the medication is indicated only for the long-term maintenance bronchodilator treatment of chronic obstructive pulmonary disease (COPD) in adults. It is not indicated for use in any other lung disease or condition, including using it to relieve acute, sudden breathing difficulties.
Q: How long do I need to take Onbrez Breezhaler before I can stop it?
Onbrez Breezhaler is designated for continuous, long-term maintenance treatment. The decision to stop treatment should be made only in consultation with a healthcare professional, as sudden discontinuation may lead to a worsening of the underlying symptoms of COPD.
Q: What is the Breezhaler device that comes with it for?
The Breezhaler device is a specialized inhaler designed to be the exclusive delivery system for the powdered medication. It contains a mechanism that punctures the capsule, allowing the user to inhale the dose effectively. Instructions for use describe specific cues that the device provides to help confirm the inhalation procedure.
Q: Can I drink coffee or alcohol when using Onbrez Breezhaler?
Official drug labels do not contain specific warnings regarding interactions with alcohol or coffee (caffeine). However, since the medication can increase heart rate and blood pressure, users should be aware that consuming large amounts of caffeine, which also has these effects, may potentially enhance them.
Q: Are there special instructions for people with liver or kidney problems?
Official regulatory guidance states that dose adjustment is generally not required for patients with mild or moderate impairment of kidney or liver function. However, the use of this drug in individuals with severe hepatic (liver) impairment has not been established, and safety information indicates limited data for this group.
Q: Can Onbrez Breezhaler be used if I am pregnant or breastfeeding?
Regulatory documents indicate that use during pregnancy is not recommended unless the anticipated benefit is determined by a physician to outweigh the potential risk to the fetus. Regarding breastfeeding, a decision is necessary to either discontinue nursing or discontinue the drug, taking into account the mother's need for the medication. The decision to use the drug is based on an individual assessment by a physician that the potential benefit outweighs the potential risk.
Q: Do studies indicate an improvement in quality of life with COPD?
Clinical studies have examined patient-reported outcomes, which include quality of life. Research using standardized assessment tools showed that findings indicated an association with statistically significant improvements in participants' symptom scores and their health-related quality of life compared to baseline measurements.
Q: Do I need to rinse my mouth after inhalation?
While some inhaled medications require a post-inhalation mouth rinse, this instruction is not universally mandatory for Onbrez Breezhaler in its official regulatory labeling as a monotherapy. Specific patient instructions, including any guidance on rinsing, are provided by the prescribing healthcare professional.
Q: How does Onbrez Breezhaler affect the ability to engage in physical activity?
The medication's mechanism is to maintain open airways, which may be associated with improved functional outcomes. Research has associated the use of this treatment with measured improvements in levels of daily physical activity, such as an increase in the average number of steps taken per day.
Q: What factors can influence the effectiveness of Onbrez Breezhaler?
Official information indicates that the medication's effectiveness relies primarily on strict adherence to the prescribed daily dosing schedule and correct technique when using the inhaler device. Additionally, taking certain drugs, such as beta-blockers, can reduce the intended bronchodilating effect of the medicine.
Q: What does "contraindications" mean in relation to Onbrez Breezhaler?
Contraindications are formally established conditions or circumstances, listed in official documents, under which the use of the medicine is strictly prohibited because the risks are considered unacceptably high. Examples include a known allergy to the drug components or using the drug for asthma treatment.
Q: How can I check if I am using the Breezhaler inhaler correctly?
The official Instructions for Use describe physical cues related to the device's function. During proper inhalation, you should hear a distinctive whirring or vibrating sound as the capsule spins inside the device. The official guidance states that the capsule should be empty after the inhalation is complete.
Q: In what cases might Onbrez Breezhaler not work?
The medicine is strictly for long-term maintenance treatment and will not relieve acute, sudden breathing problems, which is one condition where it might appear to 'not work.' Its effect may also be diminished by co-administering certain incompatible medicines, such as beta-adrenergic blockers, or if the patient's underlying disease rapidly worsens.
Q: Could there be a problem if I forget to take it several days?
As a maintenance treatment, the drug requires continuous use to sustain its beneficial effect on the airways. Discontinuation of the drug should be discussed with a healthcare provider, as missing the daily dose for multiple days can lead to a reduction in therapeutic benefit and a potential worsening of COPD symptoms.